Company Filing History:
Years Active: 1988-1993
Title: **Masami Okuno: Innovator in Radioactive Diagnostics**
Introduction
Masami Okuno, an accomplished inventor based in Osaka, Japan, has made significant strides in the field of nuclear medicine. With a total of four patents to his name, Okuno specializes in the development of innovative radioactive compounds that enhance diagnostic capabilities in medical imaging and research.
Latest Patents
Among his most notable inventions is a **radioactive benzodiazepine derivative**, which is designed to enable non-invasive detection of benzodiazepine receptors in human and animal brains. This innovative compound can dynamically trace changes in receptor concentrations, making it invaluable as a radioactive diagnostic agent in both in vitro and in vivo settings.
Another prominent patent from Okuno is the **radioactive propyl 2-iodospiroperidol**, known for its high affinity for dopamine receptors. This compound has considerable potential as a radiopharmaceutical and diagnostic agent, further solidifying Okuno's reputation in the field.
Career Highlights
Masami Okuno is associated with Sumitomo Chemical Company, Limited, where he contributes to cutting-edge research in chemical applications for medicine. His innovative work has received recognition in both academic and commercial circles, greatly impacting the landscape of diagnostic medicine.
Collaborations
Throughout his career, Okuno has collaborated with notable colleagues, including Iwao Nakatsuka and Kunio Shiba. These collaborations have fostered a dynamic research environment, allowing for shared insights and advancements in their respective fields.
Conclusion
Masami Okuno's contributions to the field of radioactive diagnostics highlight the importance of innovation in medical technology. With a keen focus on developing compounds that enhance diagnostic techniques, Okuno continues to play a crucial role in advancing nuclear medicine, benefiting both human and animal health.